CN104547964A - Traditional Chinese medicine composition and preparation for treating chronic pelvic inflammatory disease - Google Patents
Traditional Chinese medicine composition and preparation for treating chronic pelvic inflammatory disease Download PDFInfo
- Publication number
- CN104547964A CN104547964A CN201510080546.7A CN201510080546A CN104547964A CN 104547964 A CN104547964 A CN 104547964A CN 201510080546 A CN201510080546 A CN 201510080546A CN 104547964 A CN104547964 A CN 104547964A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- radix
- chinese medicine
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
- A61K36/855—Clerodendrum, e.g. glorybower
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/86—Violaceae (Violet family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Developmental Biology & Embryology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition and preparation for treating a chronic pelvic inflammatory disease. The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 10-15 parts of salviae miltiorrhizae, 10-15 parts of red peony root, 5-10 parts of peach kernel, 3-6 parts of curcuma zedoary, 6-9 parts of rhizoma corydalis, 5-12 parts of angelica sinensis, 10-15 parts of herba patriniae, 6-9 parts of honeysuckle, 10-12 parts of fructus forsythia, 10-15 parts of radix dipsaci, 10-15 parts of herba taxilli, 6-9 parts of rhizoma cyperi, 6-9 parts of pangolin, 10-20 parts of dandelion, 10-20 parts of viola philippica and 10-20 parts of folium isatidis. Conventional auxiliary materials are added to the raw materials to prepare any pharmacy-acceptable dosage form; and the medical components of the composition have synergistic effects, and have the efficacies of clearing away heat and toxic materials, strengthening the body resistance, dispersing blood stasis, astringing and arresting leucorrhea, and enriching blood. A clinical experiment proves that the preparation disclosed by the invention has the advantages of fast acting, short treatment course, low cost and no side effect on a body.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition and preparation for the treatment of chronic pelvic inflammatory disease, belong to technical field of Chinese medicines.
Background technology
Chronic pelvic inflammatory disease is woman common disease, the pelvioperitonitis produced after comprising endometritis, salpingitis and fallopian tube, ovarian abscess and diffusion, belong to the category such as motherland's medical science " married woman's stomachache ", " menoxenia ", " infertility ", " leukorrheal diseases ", have that the course of disease is long, cure rate is low, relapse rate high, for common gynecological disease, frequently-occurring disease, treat thorny, difficult, the state of an illness easily repeatedly, have a strong impact on patient work normally and live, the physical and mental health of the harm women of child-bearing age.Therefore need to take effective measures to treat, alleviate clinical symptoms, prevent disease progression, improve health status.
Although clinical treatment means are numerous at present, therapeutic effect is limited, and a lot of patient disease is effectively controlled not yet.Widely use due to antibiotic, antibacterial is made to produce drug resistance, inflammation causes pelvic cavity internal reproductive organ and connective fiber to thicken change repeatedly, and medicine is not easy infiltration, so the limitation of western medicine chronic pelvic inflammatory disease and untoward reaction are more by awareness and understanding.Play the advantage of the traditional Chinese medical science, therapeutic intervention can be carried out to chronic pelvic inflammatory disease.Though have the Chinese medicine formula of many treatment pelvic inflammatory disease at present, shortcomings many or few after all existing.
CN103550709A provides a kind of Chinese medicine for the treatment of chronic pelvic inflammatory disease, is be made up of following raw material medicaments: Radix Berberidis 30-40 part, Herba Lycopi 20-40 part, Herba Melasmatis arvensis 20-40 part, Fructus Akebiae 20-30 part, Semen Persicae 20-30 part, Herba Taraxaci 20-30 part, Radix Rubiae 15-25 part, Radix Curcumae 15-25 part, Radix Polygoni Multiflori 10-20 part, Radix Cynanchi Paniculati 8-15 part, Bulbus Lilii 8-15 part, Rhizoma Coptidis 8-12 part.Radix Berberidis in the present invention is monarch drug, and Herba Lycopi is ministerial drug, and full side plays effect of clearing away heat-damp and promoting diuresis, blood circulation promoting and blood stasis dispelling, promoting the circulation of QI to relieve pain altogether, reaches effect for the treatment of chronic pelvic inflammatory disease.But this formula has the following disadvantages: raw material valency is high, and medicine Herba Melasmatis arvensis not easily obtains.
CN104224998A provides a kind of Chinese medicine formula for the treatment of pelvic inflammatory disease, it is characterized in that comprising following technical process is: component: Fructus Aurantii Immaturus, Herba Patriniae, Poria, each 22 grams of Ramulus Cinnamomi, Rhizoma Atractylodis, Folium Isatidis, each 18 grams of Folium Mori, each 15 grams of Concha Haliotidis, Radix Platycodonis, each 10 grams of Rhizoma Corydalis, Pericarpium Citri Reticulatae, Fructus Toosendan 8 grams, Scorpio one, rice vinegar, brown sugar are appropriate; Method: above-mentioned medical material is put into porcelain, is pounded pureed, add proper amount of rice vinegar, dig every day a little soupspoon add appropriate brown sugar eat.The Chinese medicine formula it solving existing traditional treatment pelvic inflammatory disease takes effect slowly, and curative effect is not obvious, and inappropriate medication easily causes endocrine disturbance, even increases the weight of the state of an illness, is adapted to treatment female sex organs top inflammation.But this formula has the following disadvantages: be pounded pureed, after adding rice vinegar, the resting period is not long, uses the drawbacks such as inconvenient.
Summary of the invention
The invention provides a kind of therapeutic effect good, have no side effect, the Chinese medicine composition of the treatment chronic pelvic inflammatory disease of determined curative effect and preparation, to overcome the deficiencies in the prior art.
Technical scheme of the present invention is as follows:
Treat a Chinese medicine composition for chronic pelvic inflammatory disease, be made up of the crude drug of following weight portion:
Radix Salviae Miltiorrhizae 10-15 part, Radix Paeoniae Rubra 10-15 part, Semen Persicae 5-10 part, Rhizoma Curcumae 3-6 part, Rhizoma Corydalis 6-9 part, Radix Angelicae Sinensis 5-12 part, Herba Patriniae 10-15 part, Flos Lonicerae 6-9 part, Fructus Forsythiae 10-12 part, Radix Dipsaci 10-15 part, Herba Taxilli 10-15 part, Rhizoma Cyperi 6-9 part, Squama Manis 6-9 part, Herba Taraxaci 10-20 part, Herba Violae 10-20 part, Folium Isatidis 10-20 part.
It is preferred according to the present invention,
Treat a Chinese medicine preparation for chronic pelvic inflammatory disease, comprise the crude drug of following weight portion:
Radix Salviae Miltiorrhizae 15 parts, Radix Paeoniae Rubra 12 parts, 9 parts, Semen Persicae, Rhizoma Curcumae 3 parts, Rhizoma Corydalis 9 parts, Radix Angelicae Sinensis 12 parts, Herba Patriniae 15 parts, Flos Lonicerae 9 parts, Fructus Forsythiae 12 parts, Radix Dipsaci 15 parts, Herba Taxilli 15 parts, Rhizoma Cyperi 9 parts, Squama Manis 9 parts, Herba Taraxaci 20 parts, Herba Violae 20 parts, Folium Isatidis 20 parts.
Or,
Radix Salviae Miltiorrhizae 10 parts, Radix Paeoniae Rubra 15 parts, 5 parts, Semen Persicae, Rhizoma Curcumae 6 parts, Rhizoma Corydalis 6 parts, Radix Angelicae Sinensis 12 parts, Herba Patriniae 10 parts, Flos Lonicerae 9 parts, Fructus Forsythiae 10 parts, Radix Dipsaci 15 parts, Herba Taxilli 10 parts, Rhizoma Cyperi 9 parts, Squama Manis 6 parts, Herba Taraxaci 20 parts, Herba Violae 10 parts, Folium Isatidis 20 parts.
Or,
Radix Salviae Miltiorrhizae 15 parts, Radix Paeoniae Rubra 10 parts, 10 parts, Semen Persicae, Rhizoma Curcumae 3 parts, Rhizoma Corydalis 9 parts, Radix Angelicae Sinensis 5 parts, Herba Patriniae 15 parts, Flos Lonicerae 6 parts, Fructus Forsythiae 12 parts, Radix Dipsaci 10 parts, Herba Taxilli 15 parts, Rhizoma Cyperi 6 parts, Squama Manis 9 parts, Herba Taraxaci 10 parts, Herba Violae 20 parts, Folium Isatidis 10 parts.
The dosage form of preparation of the present invention for any one pharmaceutics accepts, comprises capsule preparations, dissolved granule, tablet, pill or oral liquid formulations.That is: above-described crude drug adds customary adjuvant, is conventionally prepared into the dosage form that any one pharmaceutics accepts.
Detailed Description Of The Invention:
The traditional Chinese medical science thinks that pelvic inflammatory disease occurs to invade in heresy mainly due to damp and hot, cold-damp, phlegm-damp, thoroughly do not treat not in time or, damp is lingered on, and forms expectorant with vessels of the uterus QI and blood knot of fighting, and vessels of the uterus, collaterals of the uterus QI and blood block, run not smooth, the impairment of chong and ren channels, with the passing of time, healthy energy is impaired in course of disease delay, visceral dysfunction, spleen kidney two deficiency of five ZANG-organs damages.Think wet, hot, the stasis of blood be chronic pelvic inflammatory disease commonly encountered diseases because of.Wherein " stasis of blood " is pathology key.The present invention is with heat-clearing and toxic substances removing, supporting vital QI and dispersing blood stasis for principle for the treatment of, and this is dialectical basis of the present invention.
This invention forms primarily of 16 kinds of Chinese medicines, side in Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra, Radix Dipsaci, Squama Manis for monarch drug, blood circulation promoting and blood stasis dispelling; Semen Persicae, Rhizoma Corydalis have promoting flow of QI and blood, removing damp and stopping pain effect; Radix Angelicae Sinensis has tonifying blood and regulating menstruation, promoting blood circulation and stopping pain effect; Rhizoma Curcumae, Herba Patriniae, Flos Lonicerae, Fructus Forsythiae, Herba Taraxaci, Herba Violae, Folium Isatidis have the merit of clearing away heat-damp and promoting diuresis, blood circulation promoting and blood stasis dispelling; Herba Taxilli, Rhizoma Cyperi replenishing QI to invigorate the spleen, promoting the circulation of blood removing dampness.Full side has clearing away heat-damp and promoting diuresis, stasis-dispelling and pain-killing, the double effect of enriching blood of convergence leukorrhagia stopping.
Beneficial effect of the present invention:
1. Chinese medicine preparation raw material of the present invention is easy to get, and cheap, raw material itself does not have toxic and side effects, and drug safety is reliable, and it is simple to be prepared into formulation method, not easily causes effective ingredient to run off.
2. in prescription of the present invention, each medicine drug effect has synergism, and have heat-clearing and toxic substances removing, supporting vital QI and dispersing blood stasis, the double effect of enriching blood of convergence leukorrhagia stopping, clinical effectiveness is remarkable.Clinical experiment shows, invention formulation treatment chronic pelvic inflammatory disease has instant effect, short treating period, cost advantage that is low, that have no side effect to health.
Detailed description of the invention
Following experiments example and embodiment are used for further illustrating but are not limited to the present invention.
Embodiment 1
Treat a Chinese medicine composition for chronic pelvic inflammatory disease, prescription is as follows:
Radix Salviae Miltiorrhizae 15g, Radix Paeoniae Rubra 12g, Semen Persicae 9g, Rhizoma Curcumae 3g, Rhizoma Corydalis 9g, Radix Angelicae Sinensis 12g, Herba Patriniae 15g, Flos Lonicerae 9g, Fructus Forsythiae 12g, Radix Dipsaci 15g, Herba Taxilli 15g, Rhizoma Cyperi 9g, Squama Manis 9g, Herba Taraxaci 20g, Herba Violae 20g, Folium Isatidis 20g;
Treat a Chinese medicine decoction for chronic pelvic inflammatory disease, above-mentioned raw materials medicine is fried into decoction.Potion, was divided into and sooner or later took for twice, serve on for 4 week every day.
Embodiment 2
Treat a Chinese medicine composition for chronic pelvic inflammatory disease, prescription is as follows:
Radix Salviae Miltiorrhizae 15kg, Radix Paeoniae Rubra 12kg, Semen Persicae 9kg, Rhizoma Curcumae 3kg, Rhizoma Corydalis 9kg, Radix Angelicae Sinensis 12kg, Herba Patriniae 15kg, Flos Lonicerae 9kg, Fructus Forsythiae 12kg, Radix Dipsaci 15kg, Herba Taxilli 15kg, Rhizoma Cyperi 9kg, Squama Manis 9kg, Herba Taraxaci 20kg, Herba Violae 20kg, Folium Isatidis 20kg;
Treat a medicine pill for chronic pelvic inflammatory disease, by fried for above-mentioned raw materials medicine concentrated, honey is smelt ball.Every ball weighs 0.5 gram, sooner or later respectively takes 6 balls, takes for 4 week continuously.
Embodiment 3
Treat a Chinese medicine composition for chronic pelvic inflammatory disease, prescription is as follows:
Radix Salviae Miltiorrhizae 15kg, Radix Paeoniae Rubra 12kg, Semen Persicae 9kg, Rhizoma Curcumae 3kg, Rhizoma Corydalis 9kg, Radix Angelicae Sinensis 12kg, Herba Patriniae 15kg, Flos Lonicerae 9kg, Fructus Forsythiae 12kg, Radix Dipsaci 15kg, Herba Taxilli 15kg, Rhizoma Cyperi 9kg, Squama Manis 9kg, Herba Taraxaci 20kg, Herba Violae 20kg, Folium Isatidis 20kg;
Treat a Chinese medicine capsules for chronic pelvic inflammatory disease, above-mentioned raw materials medicine is processed into fine powder, cross 100 orders with top sieve, mix homogeneously, ozone sterilization 20 minutes, technique makes capsule routinely, and every is heavy 0.5 gram, sooner or later respectively take 4-6 grain, warm water delivery service, took for 4 week continuously.
Embodiment 4
Treat a Chinese medicine composition for chronic pelvic inflammatory disease, prescription is as follows:
Radix Salviae Miltiorrhizae 15g, Radix Paeoniae Rubra 12g, Semen Persicae 9g, Rhizoma Curcumae 3g, Rhizoma Corydalis 9g, Radix Angelicae Sinensis 12g, Herba Patriniae 15g, Flos Lonicerae 9g, Fructus Forsythiae 12g, Radix Dipsaci 15g, Herba Taxilli 15g, Rhizoma Cyperi 9g, Squama Manis 9g, Herba Taraxaci 20g, Herba Violae 20g, Folium Isatidis 20g.
Treat a Chinese medicine granules for chronic pelvic inflammatory disease, above-mentioned raw materials medicine is added 500mL water, after being fully mixed into medicinal liquid, medicinal liquid is decocted into cream, be condensed into granule, pack, every bag heavy 3 grams, sooner or later respectively take 1 bag, warm water delivery service, took for 4 week continuously.
Embodiment 5
Treat a Chinese medicine composition for chronic pelvic inflammatory disease, prescription is as follows:
Radix Salviae Miltiorrhizae 150g, Radix Paeoniae Rubra 120g, Semen Persicae 90g, Rhizoma Curcumae 30g, Rhizoma Corydalis 90g, Radix Angelicae Sinensis 120g, Herba Patriniae 150g, Flos Lonicerae 90g, Fructus Forsythiae 120g, Radix Dipsaci 150g, Herba Taxilli 150g, Rhizoma Cyperi 90g, Squama Manis 90g, Herba Taraxaci 200g, Herba Violae 200g, Folium Isatidis 200g;
Treat an extract oral liquid formulation for chronic pelvic inflammatory disease, above-mentioned raw materials medicine is added 1000mL water, after being fully mixed into medicinal liquid, then oral liquid processing technology routinely, medicinal liquid is decocted and is concentrated into 200ml, oral liquid formulations of the present invention can be obtained.The instructions of taking of oral liquid: every day twice, each 10-20ml, warm water delivery service, took for 4 week continuously.
Embodiment 6
Treat a Chinese medicine composition for chronic pelvic inflammatory disease, prescription is as follows:
Radix Salviae Miltiorrhizae 15kg, Radix Paeoniae Rubra 12kg, Semen Persicae 9kg, Rhizoma Curcumae 3kg, Rhizoma Corydalis 9kg, Radix Angelicae Sinensis 12kg, Herba Patriniae 15kg, Flos Lonicerae 9kg, Fructus Forsythiae 12kg, Radix Dipsaci 15kg, Herba Taxilli 15kg, Rhizoma Cyperi 9kg, Squama Manis 9kg, Herba Taraxaci 20kg, Herba Violae 20kg, Folium Isatidis 20kg.
Treat a Chinese medicinal tablet for chronic pelvic inflammatory disease, above-mentioned raw materials medicine is processed into fine powder jointly, then tablet processing technology routinely, medicated powder is pressed into the tablet of 0.3 gram every, tablet of the present invention can be obtained.The instructions of taking of tablet: every day twice, each 3-4 sheet, warm water delivery service, took for 4 week continuously.
Embodiment 7
Treat a Chinese medicine composition for chronic pelvic inflammatory disease, prescription is as follows:
Radix Salviae Miltiorrhizae 10kg, Radix Paeoniae Rubra 15kg, Semen Persicae 5kg, Rhizoma Curcumae 6kg, Rhizoma Corydalis 6kg, Radix Angelicae Sinensis 12kg, Herba Patriniae 10kg, Flos Lonicerae 9kg, Fructus Forsythiae 10kg, Radix Dipsaci 15kg, Herba Taxilli 10kg, Rhizoma Cyperi 9kg, Squama Manis 6kg, Herba Taraxaci 20kg, Herba Violae 10kg, Folium Isatidis 20kg.
Treat a Chinese medicine capsules for chronic pelvic inflammatory disease, above-mentioned raw materials medicine is processed into fine powder jointly, cross 100 orders with top sieve, mix homogeneously, ozone sterilization 20 minutes, technique makes capsule routinely, and every is heavy 0.5 gram, sooner or later respectively take 4-6 grain, warm water delivery service, took for 4 week continuously.
Embodiment 8, a kind of Chinese medicine composition for the treatment of chronic pelvic inflammatory disease, prescription is as follows:
Radix Salviae Miltiorrhizae 15g, Radix Paeoniae Rubra 10g, Semen Persicae 10g, Rhizoma Curcumae 3g, Rhizoma Corydalis 9g, Radix Angelicae Sinensis 5g, Herba Patriniae 15g, Flos Lonicerae 6g, Fructus Forsythiae 12g, Radix Dipsaci 10g, Herba Taxilli 15g, Rhizoma Cyperi 6g, Squama Manis 9g, Herba Taraxaci 10g, Herba Violae 20g, Folium Isatidis 10g.
Treat a Chinese medicine decoction for chronic pelvic inflammatory disease, above-mentioned raw materials medicine is fried into decoction and takes, potion, was divided into and sooner or later took for twice, serve on for 4 week every day.
Experimental example 1 clinical experiment
1, clinical data
This organizes in 56 routine cases, minimum 36 years old of age, and maximum 65 years old, average 42.6 years old, the course of disease was the shortest 3 months, the longest 23 months.Clinical manifestation: hypogastralgia, lumbosacral region distending pain, bearing down, leucorrhea abnormal or menoxenia etc.All cases is and confirms, side by side except the disease such as tuberculosis, tumor through ultrasonic or CT examination and gynecologial examination.
2, Therapeutic Method
Give the decoction of the embodiment of the present invention 1 formula, fried by systematic unity of boiling medicine during clinical application, 250m L decocted into by every agent medicine, point two bags of packagings, and sooner or later respectively take 1 bag, 7 days was 1 course for the treatment of, observed for 3 courses for the treatment of.
3, criterion of therapeutical effect
Curative effect is judged with reference to " clinical disease diagnosis is according to criterion of cure ".Recovery from illness: after treatment, the disease such as hypogastralgia and waist sacrum distending pain disappears, normally, drug withdrawal is not recurred in January for gynecologial examination and physico-chemical examination.Effective: after treatment, the disease such as hypogastralgia and waist sacrum distending pain disappears or obviously alleviates, and gynecologial examination and physico-chemical examination obviously improve.Effective: after treatment, the disease such as hypogastralgia and waist sacrum distending pain alleviates, and gynecologial examination and physico-chemical examination make moderate progress.Invalid: after treatment, the disease such as hypogastralgia and waist sacrum distending pain is increased the weight of without alleviating or having, gynecologial examination and physico-chemical examination increase the weight of without improving or having before comparatively treating.
4, result
Table 1 clinical trial results
| Case (people) | Recovery from illness (people) | Effective (people) | Effectively (people) | Invalid (people) | Total effective rate (%) |
| 56 | 26 | 17 | 11 | 2 | 96.43 |
Conclusion: this organizes in 56 routine cases, recovery from illness 26 example, effective 17 examples, effective 11 examples, invalid 2 examples, total effective rate 96.43%, clinical observation known application the party treats chronic pelvic inflammatory disease, reliable for effect.
Experimental example 2 model case
Wang, 37 years old, on May 11st, 2014 went to a doctor.Persistence lower abdomen dull pain 4 years repeatedly, companion's soreness of waist and rectal tenesmus, time have awareness of defecation sense, leucorrhea amount increases, yellow skin, time be purulence, accompany abnormal flavour, have sexual anhedonia.Readme once had artificial abortion's history 3 times, namely started repeatedly to occur above-mentioned malaise symptoms after second time artificial abortion.Duo Jia hospital is all diagnosed as chronic pelvic inflammatory disease, health check-up: leucorrhea amount is many, yellow skin, and purulence, accompanies abnormal smells from the patient, lifting pain, and retroposition of uterus increases, and has tenderness, bilateral adnexa thickens, tenderness.Ultrasound diagnosis: bilateral adnexa thickens, pelvic hydrops.Diagnosis: chronic pelvic inflammatory disease.Give the Chinese medicine preparation of patient's embodiment 1, continuous 7 days was 1 course for the treatment of.After carrying out 2 course of therapy, patient is conscious, and above-mentioned symptom obviously alleviates, and B ultrasonic check prompting pelvic hydrops significantly reduces.After 4 courses for the treatment of, all diseases disappear.Recurrence is had no after following up a case by regular visits to half a year.
Experimental example 3 model case
Liu, 41 years old, within 2013, JIUYUE was gone to a doctor on the 3rd.Be interrupted lower abdominal pain 6 years, time serious, accompany lower abdomen falling inflation, time have awareness of defecation sense, leucorrhea amount increases, yellow skin, has abnormal flavour, occasionally has sexual anhedonia.Readme once had artificial abortion's history.Duo Jia hospital is all diagnosed as chronic pelvic inflammatory disease, health check-up: leucorrhea amount is many, yellow skin, and purulence, accompanies abnormal smells from the patient, lifting pain, and there is tenderness in uterus, and bilateral adnexa thickens, tenderness.Ultrasound diagnosis: bilateral adnexa thickens, a small amount of hydrops of pelvic cavity.Diagnosis: chronic pelvic inflammatory disease.Give the Chinese medicine preparation of patient's embodiment 4, continuous 7 days was 1 course for the treatment of.After carrying out 2 course of therapy, patient is conscious, and above-mentioned symptom obviously alleviates.After 6 courses for the treatment of, all diseases disappear.Recurrence is had no after following up a case by regular visits to half a year.
Claims (6)
1. treat a Chinese medicine composition for chronic pelvic inflammatory disease, it is characterized in that, raw material medicines in portions by weight is composed as follows:
Radix Salviae Miltiorrhizae 10-15 part, Radix Paeoniae Rubra 10-15 part, Semen Persicae 5-10 part, Rhizoma Curcumae 3-6 part, Rhizoma Corydalis 6-9 part, Radix Angelicae Sinensis 5-12 part, Herba Patriniae 10-15 part, Flos Lonicerae 6-9 part, Fructus Forsythiae 10-12 part, Radix Dipsaci 10-15 part, Herba Taxilli 10-15 part, Rhizoma Cyperi 6-9 part, Squama Manis 6-9 part, Herba Taraxaci 10-20 part, Herba Violae 10-20 part, Folium Isatidis 10-20 part.
2. Chinese medicine composition as claimed in claim 1, it is characterized in that, raw material medicines in portions by weight is composed as follows:
Radix Salviae Miltiorrhizae 15 parts, Radix Paeoniae Rubra 12 parts, 9 parts, Semen Persicae, Rhizoma Curcumae 3 parts, Rhizoma Corydalis 9 parts, Radix Angelicae Sinensis 12 parts, Herba Patriniae 15 parts, Flos Lonicerae 9 parts, Fructus Forsythiae 12 parts, Radix Dipsaci 15 parts, Herba Taxilli 15 parts, Rhizoma Cyperi 9 parts, Squama Manis 9 parts, Herba Taraxaci 20 parts, Herba Violae 20 parts, Folium Isatidis 20 parts.
3. Chinese medicine composition as claimed in claim 1, it is characterized in that, raw material medicines in portions by weight is composed as follows:
Radix Salviae Miltiorrhizae 10 parts, Radix Paeoniae Rubra 15 parts, 5 parts, Semen Persicae, Rhizoma Curcumae 6 parts, Rhizoma Corydalis 6 parts, Radix Angelicae Sinensis 12 parts, Herba Patriniae 10 parts, Flos Lonicerae 9 parts, Fructus Forsythiae 10 parts, Radix Dipsaci 15 parts, Herba Taxilli 10 parts, Rhizoma Cyperi 9 parts, Squama Manis 6 parts, Herba Taraxaci 20 parts, Herba Violae 10 parts, Folium Isatidis 20 parts.
4. Chinese medicine composition as claimed in claim 1, it is characterized in that, raw material medicines in portions by weight is composed as follows:
Radix Salviae Miltiorrhizae 15 parts, Radix Paeoniae Rubra 10 parts, 10 parts, Semen Persicae, Rhizoma Curcumae 3 parts, Rhizoma Corydalis 9 parts, Radix Angelicae Sinensis 5 parts, Herba Patriniae 15 parts, Flos Lonicerae 6 parts, Fructus Forsythiae 12 parts, Radix Dipsaci 10 parts, Herba Taxilli 15 parts, Rhizoma Cyperi 6 parts, Squama Manis 9 parts, Herba Taraxaci 10 parts, Herba Violae 20 parts, Folium Isatidis 10 parts.
5. the preparation of Chinese medicine composition described in any one of claim 1-4, is characterized in that, described crude drug adds customary adjuvant, is conventionally prepared into the dosage form that any one pharmaceutics accepts.
6. the preparation of Chinese medicine composition as claimed in claim 5, it is characterized in that, described preparation is capsule, granule, tablet, pill or oral liquid formulations.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510080546.7A CN104547964A (en) | 2015-02-13 | 2015-02-13 | Traditional Chinese medicine composition and preparation for treating chronic pelvic inflammatory disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510080546.7A CN104547964A (en) | 2015-02-13 | 2015-02-13 | Traditional Chinese medicine composition and preparation for treating chronic pelvic inflammatory disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104547964A true CN104547964A (en) | 2015-04-29 |
Family
ID=53065735
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510080546.7A Pending CN104547964A (en) | 2015-02-13 | 2015-02-13 | Traditional Chinese medicine composition and preparation for treating chronic pelvic inflammatory disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104547964A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104840884A (en) * | 2015-05-22 | 2015-08-19 | 郭立新 | Traditional Chinese medicinal preparation for treating chronic pelvic inflammatory disease |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1562113A (en) * | 2004-03-26 | 2005-01-12 | 刘晓峰 | Medicine for treating chronic pelvic inflammation and its preparing method |
| CN101433654A (en) * | 2008-12-19 | 2009-05-20 | 董书芳 | Chinese medicine preparation for treating women's chronic pelvic inflammatory disease and preparation method thereof |
| CN102100857A (en) * | 2010-12-28 | 2011-06-22 | 葵花药业集团（伊春）有限公司 | Medicament composition used for treating chronic pelvic inflammatory disease and preparation method thereof |
| CN103611078A (en) * | 2013-11-29 | 2014-03-05 | 青岛友铭辰生物技术有限公司 | Oral traditional Chinese medicine liquid for treating chronic pelvic inflammation and preparation method thereof |
-
2015
- 2015-02-13 CN CN201510080546.7A patent/CN104547964A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1562113A (en) * | 2004-03-26 | 2005-01-12 | 刘晓峰 | Medicine for treating chronic pelvic inflammation and its preparing method |
| CN101433654A (en) * | 2008-12-19 | 2009-05-20 | 董书芳 | Chinese medicine preparation for treating women's chronic pelvic inflammatory disease and preparation method thereof |
| CN102100857A (en) * | 2010-12-28 | 2011-06-22 | 葵花药业集团（伊春）有限公司 | Medicament composition used for treating chronic pelvic inflammatory disease and preparation method thereof |
| CN103611078A (en) * | 2013-11-29 | 2014-03-05 | 青岛友铭辰生物技术有限公司 | Oral traditional Chinese medicine liquid for treating chronic pelvic inflammation and preparation method thereof |
Non-Patent Citations (6)
| Title |
|---|
| 朱萍等: "中药治疗慢性盆腔炎50例", 《中国民间疗法》 * |
| 李占娥等: "《中西医结合妇产科护理学》", 30 September 2008 * |
| 肖国士等: "《中医秘方全书 珍藏本》", 30 April 2010 * |
| 郝卫华: "综合治理慢性盆腔炎70例疗效分析", 《临床研究》 * |
| 陈冰俊等: "《失笑散》", 31 January 2013 * |
| 黄美虹: "中医药治疗盆腔炎临床进展", 《现代中西医结合杂志》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104840884A (en) * | 2015-05-22 | 2015-08-19 | 郭立新 | Traditional Chinese medicinal preparation for treating chronic pelvic inflammatory disease |
| CN104840884B (en) * | 2015-05-22 | 2018-09-28 | 郭立新 | A kind of Chinese medicine preparation for treating chronic pelvic inflammatory disease |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102151325B (en) | Traditional Chinese medicine for treating breast diseases | |
| CN104043022A (en) | Traditional Chinese medicine composition for treating gynecologic inflammation | |
| CN105213974A (en) | One treats lymphadenomatous Chinese medicine composition and application thereof | |
| CN103550697A (en) | Traditional Chinese medicine for treating hysteromyoma | |
| CN104027522A (en) | Traditional Chinese medicament for treating acute appendicitis | |
| CN104587206A (en) | Medicament for treating bedsore and preparation method of medicament | |
| CN104623376A (en) | Medicament for treating prosopalgia | |
| CN104491775A (en) | Tradtional Chinese medicament for treating post cerebral hemorrhage depressions | |
| CN103845620A (en) | Traditional Chinese medicine for treating raynaud disease | |
| CN103784932A (en) | Traditional Chinese medicine decoction for treating hyperplasia of mammary glands | |
| CN107753880A (en) | A kind of pharmaceutical composition for treating dysmenorrhoea and preparation method thereof | |
| CN103705870A (en) | Traditional Chinese medicine composition for treating mastitis | |
| CN104547964A (en) | Traditional Chinese medicine composition and preparation for treating chronic pelvic inflammatory disease | |
| CN104800799A (en) | Traditional Chinese medicament for treating endometrial thickening with ovarian cysts | |
| CN104258275A (en) | Traditional Chinese medicinal composition for treating benign ovarian tumor with syndrome of internal blood stasis | |
| CN104887950A (en) | Mastitis treatment traditional Chinese medicine compound | |
| CN115282229B (en) | Traditional Chinese medicine composition for treating qi deficiency and blood stasis type coronary heart disease and preparation method thereof | |
| CN105998421A (en) | Traditional Chinese medicine composition for treating hysteromyoma | |
| CN102935139A (en) | Compound propolis composition for treating chronic gastroenteritis of livestock and preparation method of composition | |
| CN102940814B (en) | Medicine for treating tubal nowhere | |
| CN106177774A (en) | A kind of medicine treating pelvic inflammatory disease | |
| CN105727180A (en) | Chinese herbal medicine composition for treating mammary gland hyperplasia and preparation method thereof | |
| CN104645233A (en) | Traditional Chinese medicine preparation for treating hyperplasia of mammary glands | |
| CN104013866A (en) | Traditional Chinese medicine oral solution for treating pelvic inflammation | |
| CN105169111A (en) | Traditional Chinese medicine composition for treating chronic urticaria and application of traditional Chinese medicine composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150429 |
|
| RJ01 | Rejection of invention patent application after publication |